OBJECTIVE: To determine the clinical and imaging implications of prominent cortical and medullary veins on susceptibility-weighted images (SWI) of patients with acute stroke. METHODS: Consecutive patients with acute ischaemic stroke who had SWI scan within 24 h of symptom onset or time last-seen-well were included. The SWI series were reviewed for the presence of prominent cortical and medullary veins and were graded independently by two neuroradiologists. The correlations between prominent vein grades with different imaging and clinical variables were determined. RESULTS: Among 213 patients, prominent SWI cortical and medullary veins were identified in 35 (16.4%) patients and 20 (9.4%) patients, respectively. There was fair interobserver agreement (k = 0.314-0.338, p ≤ 0.001) for grading, and moderate agreement (k = 0.406-0.413, p ≤ 0.001) for the presence of prominent veins. Both prominent cortical and medullary veins were associated with the presence of arterial occlusion (rho = 0.232, p = 0.001; rho = 0.180, p = 0.008; respectively) and larger infarct volume (rho = 0.445, p < 0.001; rho = 0.167, p = 0.015; respectively). However, neither cortical nor medullary cortical veins were associated with the severity of symptoms at admission or clinical outcome. Prominent cortical veins were independent predictors of arterial occlusion (p = 0.018), whereas prominent medullary veins were more strongly associated with larger infarct volumes (p < 0.001). CONCLUSION: There were small but significant correlations between cortical and medullary veins on SWI with arterial occlusion and large infarct volume in acute ischaemic stroke. Advances in knowledge: In consecutive patients with acute ischaemic stroke within anterior and posterior circulation territories, prominent cortical and medullary veins on SWI series are associated with imaging biomarkers of poor clinical outcome (i.e. large infarct volume and major arterial occlusion).
OBJECTIVE: To determine the clinical and imaging implications of prominent cortical and medullary veins on susceptibility-weighted images (SWI) of patients with acute stroke. METHODS: Consecutive patients with acute ischaemic stroke who had SWI scan within 24 h of symptom onset or time last-seen-well were included. The SWI series were reviewed for the presence of prominent cortical and medullary veins and were graded independently by two neuroradiologists. The correlations between prominent vein grades with different imaging and clinical variables were determined. RESULTS: Among 213 patients, prominent SWI cortical and medullary veins were identified in 35 (16.4%) patients and 20 (9.4%) patients, respectively. There was fair interobserver agreement (k = 0.314-0.338, p ≤ 0.001) for grading, and moderate agreement (k = 0.406-0.413, p ≤ 0.001) for the presence of prominent veins. Both prominent cortical and medullary veins were associated with the presence of arterial occlusion (rho = 0.232, p = 0.001; rho = 0.180, p = 0.008; respectively) and larger infarct volume (rho = 0.445, p < 0.001; rho = 0.167, p = 0.015; respectively). However, neither cortical nor medullary cortical veins were associated with the severity of symptoms at admission or clinical outcome. Prominent cortical veins were independent predictors of arterial occlusion (p = 0.018), whereas prominent medullary veins were more strongly associated with larger infarct volumes (p < 0.001). CONCLUSION: There were small but significant correlations between cortical and medullary veins on SWI with arterial occlusion and large infarct volume in acute ischaemic stroke. Advances in knowledge: In consecutive patients with acute ischaemic stroke within anterior and posterior circulation territories, prominent cortical and medullary veins on SWI series are associated with imaging biomarkers of poor clinical outcome (i.e. large infarct volume and major arterial occlusion).
Authors: Oliver C Singer; Wiebke Kurre; Marek C Humpich; Matthias W Lorenz; Andreas Kastrup; David S Liebeskind; Goetz Thomalla; Jens Fiehler; Joachim Berkefeld; Tobias Neumann-Haefelin Journal: Stroke Date: 2009-06-04 Impact factor: 7.914
Authors: S Soize; A L Batista; C Rodriguez Regent; D Trystram; M Tisserand; G Turc; I Serre; W Ben Hassen; M Zuber; D Calvet; J-L Mas; J-F Meder; J Raymond; L Pierot; C Oppenheim; O Naggara Journal: Eur J Neurol Date: 2015-03-19 Impact factor: 6.089
Authors: Rajeev K Verma; Kety Hsieh; Pascal P Gratz; Adrian C Schankath; Pasquale Mordasini; Christoph Zubler; Frauke Kellner-Weldon; Simon Jung; Gerhard Schroth; Jan Gralla; Marwan El-Koussy Journal: Eur J Radiol Date: 2014-05-17 Impact factor: 3.528
Authors: Alex Rovira; Patricia Orellana; Jose Alvarez-Sabín; Juan F Arenillas; Xavier Aymerich; Elisenda Grivé; Carlos Molina; Antoni Rovira-Gols Journal: Radiology Date: 2004-06-23 Impact factor: 11.105
Authors: Salvatore Rudilosso; Ernest Chui; Michael S Stringer; Michael Thrippleton; Francesca Chappell; Gordon Blair; Daniela Jaime GarcÃa; Fergus Doubal; Iona Hamilton; Anna Kopczak; Michael Ingrish; Danielle Kerkhofs; Walter H Backes; Julie Staals; Robert van Oostenbrugge; Marco Duering; Martin Dichgans; Joanna M Wardlaw Journal: Neurology Date: 2022-05-23 Impact factor: 11.800
Authors: Hyung Jin Lee; Hong Gee Roh; Sang Bong Lee; Yoo Sung Jeon; Jeong Jin Park; Taek-Jun Lee; Yu Jin Jung; Jin Woo Choi; Young Il Chun; Hee Jong Ki; Junsoo Cho; Ji Sung Lee; Hyun Jeong Kim Journal: Sci Rep Date: 2021-11-01 Impact factor: 4.379